Skip to content

STOPAH TRIAL

Thank you Quynh Vu for your excellent overview of the STOPAH trial (Prednisolone or Pentoxifylline for Alcoholic Hepatitis)

Conclusions of the study:

  • Pentoxifylline did not improve survival in patients with alcoholic hepatitis
  • Prednisolone was associated with a reduction in 28-day mortality that did not reach significance and with no improvement in outcomes at 90 days or 1 year

Main points: STOPAH PowerPoint

Read Full Article: STOPAH Trial

No Url Found
Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.